Amicus (FOLD) Stock Research

FOLD

· FOLD

Over a week ago

Paulson takes new stake in Amicus, cuts position in Madrigal Pharma

May 15, 5:16 PM

BioMarin completes acquisition of Amicus Therapeutics

Apr 27, 8:47 AM

BioMarin resumed with an Overweight at Morgan Stanley

Apr 27, 6:16 AM

BioMarin price target lowered to $85 from $97 at BofA

Mar 11, 6:32 AM

BioMarin price target raised by $6 at Canaccord, here's why

Feb 26, 8:39 AM

BioMarin price target lowered by $20 at Guggenheim, here's why

Feb 25, 6:54 AM

BioMarin price target lowered by $3 at Oppenheimer, here's why

Feb 24, 7:48 AM

Amicus reports Q4 EPS 10c, consensus 18c

FOLD

Feb 20, 4:04 PM

Amicus presents new long-term data for Galafold, Pombiliti+ Opfolda

FOLD

Feb 3, 8:13 AM

Amicus just downgraded at Jefferies, here's why

FOLD

Jan 22, 5:13 AM

BioMarin just upgraded at Canaccord, here's why

Jan 20, 5:05 AM

Amicus just downgraded at Guggenheim, here's why

FOLD

Jan 5, 9:24 AM

What You Missed On Wall Street On Monday

+16

Dec 29, 4:35 PM

Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal

+16

Dec 29, 12:05 PM

Amicus just downgraded at Leerink, here's why

FOLD

Dec 29, 4:23 AM

BioMarin price target raised by $20 at Truist, here's why

Dec 23, 7:38 AM

Arcellx initiated, Cummins upgraded: Wall Street's top analyst calls

+10

Dec 22, 9:47 AM

BofA moves to No Rating on Amicus after BioMarin deal

Dec 22, 6:25 AM

Amicus just downgraded at Citi, here's why

FOLD

Dec 21, 8:38 PM

Amicus just downgraded at TD Cowen, here's why

FOLD

Dec 19, 6:54 PM

What You Missed On Wall Street On Friday

+34

Dec 19, 4:27 PM

William Blair views BioMarin acquisition of Amicus as 'strategic fit'

Dec 19, 1:48 PM

Midday Fly By: Nike reports Q2 beat, TikTok to sell U.S. unit

+24

Dec 19, 12:03 PM

Amicus rises 30.4%

FOLD

Dec 19, 12:01 PM

Amicus just downgraded at Needham, here's why

FOLD

Dec 19, 11:12 AM

Charts

Over a week ago

Paulson takes new stake in Amicus, cuts position in Madrigal Pharma

May 15, 5:16 PM

BioMarin completes acquisition of Amicus Therapeutics

Apr 27, 8:47 AM

BioMarin resumed with an Overweight at Morgan Stanley

Apr 27, 6:16 AM

BioMarin price target lowered to $85 from $97 at BofA

Mar 11, 6:32 AM

BioMarin price target raised by $6 at Canaccord, here's why

Feb 26, 8:39 AM

BioMarin price target lowered by $20 at Guggenheim, here's why

Feb 25, 6:54 AM

BioMarin price target lowered by $3 at Oppenheimer, here's why

Feb 24, 7:48 AM

Amicus reports Q4 EPS 10c, consensus 18c

FOLD

Feb 20, 4:04 PM

Amicus presents new long-term data for Galafold, Pombiliti+ Opfolda

FOLD

Feb 3, 8:13 AM

Amicus just downgraded at Jefferies, here's why

FOLD

Jan 22, 5:13 AM

BioMarin just upgraded at Canaccord, here's why

Jan 20, 5:05 AM

Amicus just downgraded at Guggenheim, here's why

FOLD

Jan 5, 9:24 AM

What You Missed On Wall Street On Monday

+16

Dec 29, 4:35 PM

Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal

+16

Dec 29, 12:05 PM

Amicus just downgraded at Leerink, here's why

FOLD

Dec 29, 4:23 AM

BioMarin price target raised by $20 at Truist, here's why

Dec 23, 7:38 AM

Arcellx initiated, Cummins upgraded: Wall Street's top analyst calls

+10

Dec 22, 9:47 AM

BofA moves to No Rating on Amicus after BioMarin deal

Dec 22, 6:25 AM

Amicus just downgraded at Citi, here's why

FOLD

Dec 21, 8:38 PM

Amicus just downgraded at TD Cowen, here's why

FOLD

Dec 19, 6:54 PM

What You Missed On Wall Street On Friday

+34

Dec 19, 4:27 PM

William Blair views BioMarin acquisition of Amicus as 'strategic fit'

Dec 19, 1:48 PM

Midday Fly By: Nike reports Q2 beat, TikTok to sell U.S. unit

+24

Dec 19, 12:03 PM

Amicus rises 30.4%

FOLD

Dec 19, 12:01 PM

Amicus just downgraded at Needham, here's why

FOLD

Dec 19, 11:12 AM

Company News

Charts

FOLD

· FOLD

Company News

Charts

FOLD

· FOLD